New Stitch-Device aims to seal artery holes after heart procedures
NCT ID NCT06851481
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new device called the Ladera LBC System that uses stitches to close the hole in the femoral artery after catheter-based heart or blood vessel procedures. The study will enroll 55 adults who are scheduled for elective procedures using large sheaths (10 to 24 French). The main goals are to see if the device stops bleeding quickly and safely, with no major complications within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ladera LBC System (a suture-based device to close the artery)
What this could lead to
If it works, this device could offer a faster, safer way to close the femoral artery after heart or blood vessel procedures, reducing complications.
What could go wrong
This is a small, early study with only 55 people and no comparison group. The device may not work as well as existing methods, and there is a risk of bleeding or other access-site problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR CLOSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Sint-Jan Brugge AV
RECRUITINGBruges, Belgium
Contact
-
Erasmus University Medical Center
RECRUITINGRotterdam, Netherlands
Contact
-
Jessie McPherson Private Hospital
RECRUITINGClayton, Clayton VIC, 3168, Australia
Contact
-
Macquarie University
RECRUITINGSydney, New South Wales, Australia
Contact
-
Monash Health, Victoria Heart Hospital
RECRUITINGMelbourne, Victoria, Australia
Contact
-
OLVG Amsterdam
RECRUITINGAmsterdam, Netherlands
Contact